S39 - Movement Disorders: Functional and Structural Imaging in Parkinson's Disease

Event Time: Thursday April 27, 2017 1:00 pm to 3:00 pm
Topic(s): Movement Disorders
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Volumetric analysis of limbic structures in patients with functional movement disorders Carine Maurer, MD, PhD
Disclosure:
Dr. Maurer has nothing to disclose.

1:12 PM 002 Inferior parietal cortex as a hub of loss of inhibition and maladaptive plasticity Kristina Simonyan
Disclosure:
Dr. Simonyan has received personal compensation for activities with Dystonia Medical Research Foundation as an advisor.

1:24 PM 003 Distinct Mesocorticolimbic blood flow response to dopamine therapy in patients with Parkinson′s disease and compulsive reward-driven behaviors Daniel Claassen, MD
Disclosure:
Dr. Claassen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Neuroscience, Lundbeck, Acadia, AbbVie. Dr. Claassen has received research support from NIH/NINDS, Michael J. Fox Foundation, Huntington Disease Society of America, Vaccinex, AbbVie, Auspex Pharmaceuticals.

1:36 PM 004 Hippocampal and entorhinal cortex atrophy across the Parkinson′s disease cognitive impairment spectrum Roshni Patel, MD
Disclosure:
Dr. Patel has nothing to disclose.

1:48 PM 005 The effects of different modalities of gait training on brain activation in patients with Parkinson′s disease: an fMRI study Inbal Maidan
Disclosure:
Dr. Mirelman has nothing to disclose.

2:00 PM 006 Effects of Subthalamic Stimulation in Elderly patients with Parkinson′s Disease Vibhash Sharma, MD
Disclosure:
Dr. Sharma has nothing to disclose.

2:12 PM 007 Identification of Usp8 as a toxicity modifying Deubiquitinase for α-synuclein Zoi Alexopoulou, MD, PhD
Disclosure:
Dr. Alexopoulou has nothing to disclose.

2:24 PM 008 Glucose-regulated protein 78 (GRP78) in plasma and CSF is associated with Parkinson′s disease. Deepak Gupta, MBBS
Disclosure:
Dr. Gupta has nothing to disclose.

Register Now

Related Courses